Semaphorins 4A and 4D in chronic inflammatory diseases

Inflamm Res. 2017 Feb;66(2):111-117. doi: 10.1007/s00011-016-0983-5. Epub 2016 Aug 23.

Abstract

Long-term inflammatory processes directed at a particular endogenous or exogenous antigen, or sometimes of unknown etiology, form the pathogenetic basis for many debilitating conditions, such as cardiovascular, pulmonary, autoimmune, neurologic diseases, and cancer. Recent discoveries of neuroimmune semaphorins 4A and 4D (Sema4A and Sema4D, respectively) expression and function in the immune system and their key regulatory roles in fine tuning of inflammatory processes made them the molecules of interest for a potential immunotherapy. In this short review, we discuss the current knowledge in the Sema4A and Sema4D actions in chronic inflammation underlying the outlined above diseases.

Keywords: Asthma; Autoimmune diseases; Cancer; Chronic inflammation; Semaphorins.

Publication types

  • Review

MeSH terms

  • Animals
  • Antigens, CD / immunology*
  • Arthritis, Rheumatoid / immunology
  • Asthma / immunology
  • Atherosclerosis / immunology
  • Humans
  • Inflammatory Bowel Diseases / immunology
  • Lupus Erythematosus, Systemic / immunology
  • Multiple Sclerosis / immunology
  • Myocarditis / immunology
  • Neoplasms / immunology
  • Nerve Tissue Proteins / immunology
  • Receptors, Cell Surface / immunology
  • Semaphorins / immunology*

Substances

  • Antigens, CD
  • CD100 antigen
  • Nerve Tissue Proteins
  • PLXNB1 protein, human
  • Receptors, Cell Surface
  • SEMA4A protein, human
  • Semaphorins